Importantly, since rejection to islet transplant in T1D recipients can be facilitated by both allorejection and recurrent autoimmunity (4, 7), the capacity of TGF-β1 PLGA MPs to generate antigen-specific iTregs could convey additional benefits. The gene discussed is TGFB1; the disease is type 1 diabetes mellitus.